Figure 2. SHP2MAC-KO reduces myocardial infarct size in mice. (A) TTC results; (B) percentage of infarct size in each group; (C) Plot of Masson Staining result; (D) Myocardial infarction area statistics. **P<0.01, ns P>0.05.